About this trial
This exploratory study is designed to ensure the safety of HIV-infected volunteers who complete research protocols that include an analytic treatment interruption (ATI). This is a prospective cohort study of volunteers who were diagnosed with HIV during early acute HIV infection, treated with antiretroviral therapy (ART) and subsequently enrolled in a clinical study that included ATI. After completion of study participation that involves ATI, participants will be recruited into this study for continued clinical and laboratory monitoring.
Eligibility criteria
Qualifiers
Man or woman aged ≥18 years.
Enrolled in RV254 study.
Completed clinical research protocol that included ATI within one month of enrollment in this protocol.
Able and willing to provide written informed consent or, in the case of illiteracy, witnessed verbal informed consent with documentation of a thumbprint in lieu of a signature.
Disqualifiers
History of a medical or psychiatric condition that, in the opinion of investigator, would jeopardize the safety or rights of the subject, such as a condition that would interfere with or serve as a contraindication to adherence to the study protocol or ability to give informed consent.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
SEARCH Research Foundation
Lead sponsor
US Military HIV Research Program
Collaborator